Search Login Register

Agranulocytosis (Granulocytopenia) Summary

Description: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Also Known As: Granulocytopenia; Agranulocytoses; Granulocytopenias

Networked: 3096 relevant articles (122 outcomes, 164 trials/studies) for this Disease

Key Drugs and Agents for Agranulocytosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Clozapine (Clozaril) : 29 outcomes 33 studies in 434 results : FDA 8 Generic
  2. Granulocyte Colony-Stimulating Factor (G-CSF) : 18 outcomes 16 studies in 190 results : IBA
  3. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) : 4 outcomes 6 studies in 69 results : IBA
  4. Intercellular Signaling Peptides and Proteins (Growth Factors) : 4 outcomes 2 studies in 35 results : IBA
  5. Antipsychotic Agents (Antipsychotics) : 4 outcomes 1 study in 52 results : IBA
  6. Methimazole (Thiamazole) : 3 outcomes 3 studies in 91 results : FDA 9 Generic
  7. Anti-Bacterial Agents (Antibiotics) : 3 outcomes 3 studies in 88 results : IBA
  8. Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole) : 3 outcomes 2 studies in 37 results : FDA 6 Generic
  9. olanzapine (Zyprexa) : 3 outcomes 2 studies in 37 results : FDA 13
  10. Filgrastim (Neupogen) : 3 outcomes 2 studies in 19 results : FDA 2
Show All >>

Diseases Related to Agranulocytosis

  1. Infection
  2. Schizophrenia (Dementia Praecox)
  3. Neutropenia
  4. Neoplasms (Cancer)
  5. Fever (Fevers)
Show All >>

Key Therapies for Agranulocytosis

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 9 outcomes 9 studies in 207 results
  2. Leukocyte Transfusion : 1 outcome 1 study in 6 results
  3. Catheters : 1 outcome in 16 results
  4. Splenectomy : 1 outcome in 10 results
  5. Plasmapheresis : 1 outcome in 10 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.